A rogue hybrid lymphocyte, bearing characteristics of both B and T cells, may play a role in driving autoimmunity in the disease, although the mechanism is far from clear. After a year teaching an ...

Transplanting insulin-producing cells along with engineered blood ... in response to rising blood glucose levels. In type 1 diabetes, the immune system attacks and slowly destroys these islets ...

T cell-mediated type 1 diabetes in humans. The reasons for the preferred popularity of the mouse model include a better-defined genome, more monoclonal reagents for the analysis of immune system ...

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of ... implant designed to protect them from immune surveillance, but still allow them ...